NOVONIX Ltd Files 6-K with Substantial Holder Update
Ticker: NVNXF · Form: 6-K · Filed: Dec 9, 2024 · CIK: 1859795
Sentiment: neutral
Topics: filing-update, substantial-holder
TL;DR
NOVONIX filed a 6-K with a substantial holder change – watch for ownership shifts.
AI Summary
NOVONIX Limited filed a Form 6-K on December 9, 2024, reporting information as of December 9, 2024. The filing includes Exhibit 99.1, which is Appendix 3H (Notification of Change of Interests of Substantial Holder). The company is incorporated in Australia and its fiscal year ends on December 31.
Why It Matters
This filing provides an update on significant changes in share ownership, which can signal shifts in investor confidence or strategic direction.
Risk Assessment
Risk Level: medium — Changes in substantial holder interests can indicate potential shifts in company strategy or investor sentiment, requiring closer monitoring.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- December 9, 2024 (date) — Filing Date
- Appendix 3H (document) — Included Exhibit
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as of December 9, 2024, including Exhibit 99.1, which is an Appendix 3H (Notification of Change of Interests of Substantial Holder).
What is the company's fiscal year end?
NOVONIX Limited's fiscal year ends on December 31.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Does NOVONIX Limited file its annual reports under Form 20-F or Form 40-F?
NOVONIX Limited files its annual reports under cover of Form 20-F.
What is the Commission File Number for this filing?
The Commission File Number for this filing is 001-41208.
Filing Stats: 197 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-12-09 16:06:58
Filing Documents
- nvx-6k-dec-24-12-09_app3.htm (6-K) — 18KB
- nvx-ex99_1.htm (EX-99.1) — 53KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-134516.txt ( ) — 74KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: December 9, 2024